resveratrol has been researched along with nystatin a1 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Athias, A; Delmas, D; Gambert, P; Grazide, S; Latruffe, N; Laurent, G; Micheau, O; Rébé, C; Solary, E | 1 |
Athias, A; Colin, D; Delmas, D; Gambert, P; Hichami, A; Jacquel, A; Jeanningros, S; Latruffe, N; Limagne, E; Lizard, G; Solary, E | 1 |
3 other study(ies) available for resveratrol and nystatin a1
Article | Year |
---|---|
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Blotting, Western; Carcinoma; Caspases; Cell Line, Tumor; Colonic Neoplasms; fas Receptor; Flow Cytometry; Humans; Ligands; Lipid Metabolism; Lipids; Membrane Glycoproteins; Membrane Microdomains; Mitochondria; Nystatin; Proto-Oncogene Proteins c-bcl-2; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; Resveratrol; Signal Transduction; Stilbenes; Time Factors; TNF-Related Apoptosis-Inducing Ligand; Transfection; Tumor Necrosis Factor-alpha | 2004 |
Endocytosis of resveratrol via lipid rafts and activation of downstream signaling pathways in cancer cells.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Antineoplastic Agents, Phytogenic; Apoptosis; beta-Cyclodextrins; Blotting, Western; Colonic Neoplasms; Endocytosis; Extracellular Signal-Regulated MAP Kinases; Filipin; Flow Cytometry; Focal Adhesion Kinase 1; GRB2 Adaptor Protein; Humans; Immunoenzyme Techniques; Immunoprecipitation; Integrin alphaVbeta3; Membrane Microdomains; Nystatin; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-fyn; ras Proteins; Resveratrol; Signal Transduction; Son of Sevenless Proteins; Stilbenes; Tumor Cells, Cultured | 2011 |